• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管腺癌和鳞癌的独特遗传异常。

Distinct genetic aberrations in oesophageal adeno and squamous carcinoma.

机构信息

Laboratory of Molecular Oncology Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India.

出版信息

Eur J Clin Invest. 2013 Dec;43(12):1233-9. doi: 10.1111/eci.12163. Epub 2013 Sep 17.

DOI:10.1111/eci.12163
PMID:24102414
Abstract

BACKGROUND

The two main oesophageal cancer subtypes namely adenocarcinoma and squamous cell carcinoma exhibit interesting clinical, pathological and geographical variations with the former being more common in the West and the latter in Asia.

MATERIALS AND METHODS

We evaluated status of p53, EGFR, Wnt and HPV in addition to microsatellite instability and loss of heterozygosity of several chromosomal loci in the two oesophageal cancer subtypes from India. The comparative analysis was extended to two oesophageal adenosquamous mixed cancer samples.

RESULTS

Our results reveal a high frequency of EGFR overexpression in ESCC as against EAC, while Wnt activation was a significantly more common event in EAC as against ESCC. Frequencies of p53 perturbations were not significantly different in the two subtypes. Interestingly, the EGFR and Wnt status in adenocarcinoma and squamous components of the two oesophageal adenosquamous cancer samples were identical to primary tumours. In addition, no common molecular aberration (including instability and loss of heterozygosity) in several microsatellites was detected in DNA isolated from the two components in both adenosquamous cancer samples.

CONCLUSIONS

Our results reveal the presence of distinct aberrations in oesophageal adenocarcinoma and squamous cell carcinoma which are replicated in the respective components of adenosquamous cancers. The study therefore suggests perhaps an independent origin of the two components of oesophageal adenosquamous mixed cancer.

摘要

背景

两种主要的食管癌亚型,即腺癌和鳞状细胞癌,表现出有趣的临床、病理和地理变化,前者在西方更为常见,后者在亚洲更为常见。

材料和方法

我们评估了来自印度的两种食管癌亚型(即食管腺癌和食管鳞状细胞癌)中 p53、EGFR、Wnt 和 HPV 的状态,以及几个染色体位点的微卫星不稳定性和杂合性丢失。比较分析还扩展到了两种食管腺鳞混合癌样本。

结果

我们的结果显示,在 ESCC 中 EGFR 的过度表达频率高于 EAC,而在 EAC 中 Wnt 的激活是一个更为常见的事件。两种亚型中 p53 改变的频率没有显著差异。有趣的是,两种食管腺鳞癌样本中腺癌和鳞状成分的 EGFR 和 Wnt 状态与原发性肿瘤相同。此外,在两个腺鳞癌样本的两个成分中分离的 DNA 中,没有检测到几个微卫星中常见的分子异常(包括不稳定性和杂合性丢失)。

结论

我们的结果揭示了食管腺癌和鳞状细胞癌中存在明显的异常,这些异常在腺鳞癌的相应成分中得到了复制。因此,该研究表明食管腺鳞混合癌的两个成分可能具有独立的起源。

相似文献

1
Distinct genetic aberrations in oesophageal adeno and squamous carcinoma.食管腺癌和鳞癌的独特遗传异常。
Eur J Clin Invest. 2013 Dec;43(12):1233-9. doi: 10.1111/eci.12163. Epub 2013 Sep 17.
2
p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.低发率德国食管鳞状细胞癌患者队列中的p53密码子72多态性、杂合性缺失及高危型人乳头瘤病毒感染
Oncol Rep. 2007 May;17(5):1243-8.
3
Abnormalities of chromosome 17 in oesophageal cancer.食管癌中17号染色体的异常
J Clin Pathol. 2007 Sep;60(9):990-4. doi: 10.1136/jcp.2006.042416. Epub 2006 Oct 17.
4
Genetic features of metachronous esophageal cancer developed in Hodgkin's lymphoma or breast cancer long-term survivors: an exploratory study.霍奇金淋巴瘤或乳腺癌长期幸存者发生的异时性食管癌的遗传特征:一项探索性研究。
PLoS One. 2015 Jan 22;10(1):e0117070. doi: 10.1371/journal.pone.0117070. eCollection 2015.
5
Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.肺腺鳞癌中从鳞状细胞癌向腺癌的转变。
Am J Pathol. 2000 Apr;156(4):1289-98. doi: 10.1016/S0002-9440(10)64999-1.
6
Infrequent microsatellite instability in oesophageal cancers.食管癌中罕见的微卫星不稳定性
Br J Cancer. 1997;75(9):1336-9. doi: 10.1038/bjc.1997.226.
7
p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China.中国高发病区食管鳞状细胞癌中p53过表达与人乳头瘤病毒(HPV)感染情况
Anticancer Res. 1997 Jan-Feb;17(1B):709-15.
8
Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.p21(WAF1)表达失调的过表达影响手术切除的食管鳞状细胞癌患者的生存。
Ann Thorac Surg. 2005 Sep;80(3):1007-16. doi: 10.1016/j.athoracsur.2005.03.050.
9
Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.中国地理区域局限性食管鳞状细胞癌组中p53的突变谱。
Cancer. 2004 Aug 15;101(4):834-44. doi: 10.1002/cncr.20437.
10
The detection of oesophageal adenocarcinoma by serum microsatellite analysis.通过血清微卫星分析检测食管腺癌
Eur J Surg Oncol. 2006 Nov;32(9):954-60. doi: 10.1016/j.ejso.2006.02.015. Epub 2006 Apr 3.

引用本文的文献

1
Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma.小分子抑制剂BMS-754807抑制胰岛素样生长因子1受体/胰岛素受体信号传导可提高实验性食管腺癌的生存率。
Cancers (Basel). 2024 Sep 17;16(18):3175. doi: 10.3390/cancers16183175.
2
Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers-Improvements in Clinical Efficacy and Safety.纳米白蛋白结合型紫杉醇治疗胃肠道癌症——临床疗效与安全性的改善
Biomedicines. 2023 Jul 15;11(7):2000. doi: 10.3390/biomedicines11072000.
3
Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer.
细胞周期蛋白依赖性激酶抑制剂黄酮哌醇对c-Myc过表达食管癌的治疗潜力
Front Pharmacol. 2021 Sep 21;12:746385. doi: 10.3389/fphar.2021.746385. eCollection 2021.
4
Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer Center.近2000例胃肠道、胰腺和胆管腺癌中高微卫星不稳定性/错配修复缺陷的发生情况:来自德国大型综合癌症中心的一项研究
Front Oncol. 2021 Jul 22;11:569475. doi: 10.3389/fonc.2021.569475. eCollection 2021.
5
Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma.靶向 KDR 和蛋白酶体抑制剂在食管鳞癌治疗中的潜在作用。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820948060. doi: 10.1177/1533033820948060.
6
Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma.拉帕替尼联合福瑞替尼治疗 HER2 和 MET 共激活的实验性食管腺癌的协同作用。
Sci Rep. 2019 Nov 26;9(1):17608. doi: 10.1038/s41598-019-54129-7.
7
Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma.食管/胃食管交界处腺癌中 HER2 阴性的罕见侵袭性亚型——腺鳞癌的鉴定。
Am J Clin Oncol. 2019 Feb;42(2):190-195. doi: 10.1097/COC.0000000000000495.
8
Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.爱泼斯坦-巴尔病毒和错配修复缺陷状态在食管癌和胃癌之间存在差异:一项大型多中心研究。
Eur J Cancer. 2018 May;94:104-114. doi: 10.1016/j.ejca.2018.02.014. Epub 2018 Mar 20.
9
The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability . PD-L1.PD-1抑制剂在胃食管癌中的前景:微卫星不稳定性与程序性死亡配体1
J Gastrointest Oncol. 2016 Oct;7(5):771-788. doi: 10.21037/jgo.2016.08.06.
10
Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro.通过Hdm2-siRNA靶向基因疗法在体外增强TE1、TE8和TE11食管鳞状癌细胞系的放射敏感性。
Bioimpacts. 2016;6(2):93-8. doi: 10.15171/bi.2016.13. Epub 2016 Jun 28.